ArticleCancer research communications2021

BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin.

Shino Endo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.